1
Ketogenic Diet for Treating Infantile Spasms: ½ year experience Mortensen M¹, Nielsen H¹, Povlsen JH¹, Johansen D¹, Daneman K¹, Miranda MJ¹ ¹Danish Epilepsy Centre, Dianalund, Denmark Introduction •Infantile spasms (IS) are a severe epilepsy syndrome in early childhood with a variety of aetiologies •IS have a high morbidity and are difficult to treat¹ •Cessation of spasms by early and appropriate treatment is essential for improving outcome •Ketogenic Diet (KD) has been successfully used for treating medically refractory IS² ³ Aim • To evaluate the effectiveness of KD for treating medically refractory IS, regarding tolerability and seizure reduction (retrospective study). Patients and methods •Retrospective study of the first 8 infants treated with KD •All infants had previously been treated with Vigabatrin, Hydrocortisone and a mean of 5 (3-7) antiepileptic drugs (AEDs) (VPA, TPM, LEV, Zonisamide, benzodiazepines) . . Table 2 - Results Table 1 - Patient data Table 3 - The Ketogenic Diet r References Conclusions KD has shown to be an effective and safe treatment medically refractory IS The clinical response is positive (measured by redu cessation of spasms) in most infants (7/8) and the tolerability good (8/8) Reduction (6/8)/ interruption (2/8) of AEDs is an a positive effect We can not conclude on EEG improvement in this stud [email protected] [email protected] Cur ren t Age (mo) Gen - der Diagnosis Epileps y onset (mo) Diet start (mo) EEG before KD 1 19 F Cryptogenic West Syndrome 4 10 Hypsarritmia 2 22 M Symptomatic West Syndrome (Deletion 22q13) 9 16 Hypsarritmia 3 18 M Symptomatic West Syndrome (Trisomy 21-Down S.) 5 12 Hypsarritmia 4 18 F Early Myoclonic Encephalopathy 6 12 Suppression-burst 5 18 M Cryptogenic West Syndrome 4 13 Multifocal 6 16 M Symptomatic West Syndrome (Multiple cerebral malformations) 2 12 Multifocal 7 25 M Cryptogenic West Syndrome 3 21 Hypsarritmia 8 18 M Cryptogenic West Syndrome 3 15 Hypsarritmia Seizures before KD (mean/ week) Seizures after 1 mo (mean/ week) Seizures after 3 mo (mean/ week) Seizures after 6 mo (mean/week) Total Seizure reductio n EEG at follow-up 1 80 18 11 10 88 % Multifocal 2 210 0 0 0 100 % n/a 3 20 19 18 out of diet 10 % Hypsarritmia 4 76 57 12 62 18 % Slight improvement 5 450 113 63 n/a 86 % n/a* 6 120 147 37 n/a 68 % n/a* 7 60 29 20 n/a 66 % n/a* 8 40 28 20 n/a 50 % Multifocal Diet start Kcal / Ratio / Carbsxday Diet after 1 mo Kcal / Ratio / Carbsx day Diet after 3 mo Kcal / Ratio / Carbsxday Diet after 6 mo Kcal / Ratio / Carbsxday 1 720 / 4:1 / 5,5 g 720 / 4:1 / 5,5 g 750 / 4:1 / 5,5 g 860 / 4:1 / 5,5 g 2 550 / 4:1 / 2 g 700 / 3,5:1 / 5 g 700 / 3,5:1 / 5 g 810 / 3,5:1 / 5 g 3 550 / 4:1 / 2,3 g 580 / 4:1 / 2,4 g 680 / 4:1 / 2,8 g out of diet 4 450 / 3:1 / 1,8 g 525 / 3:1 / 2,1 g 565 / 3:1 / 2,1 g 610 / 4:1 /2,3 g 5 600 / 3:1 / 4 g 600 / 3:1 / 4 g 600 / 4:1 / 4 g n/a* 6 700 / 4:1 / 4 g 600 / 4:1 / 3 g 450 / 4:1 / 3 g n/a* 7 700 / 4:1 / 5 g 700 / 4:1 / 5 g 700 / 4:1 / 5 g n/a* 8 565 / 3:1 / 3,5 g 605 / 3:1 / 3,5 g 617 / 4:1 / 2,5 g n/a* *n/a= non available References: ¹Cochrane Database Syst Rev 2002; ²Kossoff EH, Pediatrics 2002; ³Eun SH et al, Brain Dev 2006 Patient 1

Ketogenic Diet for Treating Infantile Spasms: ½ year experience Mortensen M¹, Nielsen H¹, Povlsen JH¹, Johansen D¹, Daneman K¹, Miranda MJ¹ ¹Danish Epilepsy

Embed Size (px)

Citation preview

Page 1: Ketogenic Diet for Treating Infantile Spasms: ½ year experience Mortensen M¹, Nielsen H¹, Povlsen JH¹, Johansen D¹, Daneman K¹, Miranda MJ¹ ¹Danish Epilepsy

Ketogenic Diet for Treating Infantile Spasms:½ year experience

Mortensen M¹, Nielsen H¹, Povlsen JH¹, Johansen D¹, Daneman K¹, Miranda MJ¹ ¹Danish Epilepsy Centre, Dianalund, Denmark

Introduction•Infantile spasms (IS) are a severe epilepsy syndrome in early childhood with a variety of aetiologies•IS have a high morbidity and are difficult to treat¹•Cessation of spasms by early and appropriate treatment is essential for improving outcome•Ketogenic Diet (KD) has been successfully used for treating medically refractory IS² ³

Aim• To evaluate the effectiveness of KD for treating medically refractory IS, regarding tolerability and seizure reduction (retrospective study).

Patients and methods•Retrospective study of the first 8 infants treated with KD•All infants had previously been treated with Vigabatrin, Hydrocortisone and a mean of 5 (3-7) antiepileptic drugs (AEDs) (VPA, TPM, LEV, Zonisamide, benzodiazepines)

..

Table 2 - Results

Table 1 - Patient data

Table 3 - The Ketogenic Diet

rReferences

Conclusions•KD has shown to be an effective and safe treatment for medically refractory IS•The clinical response is positive (measured by reduction or cessation of spasms) in most infants (7/8) and the tolerability good (8/8)•Reduction (6/8)/ interruption (2/8) of AEDs is an additional positive effect •We can not conclude on EEG improvement in this study

[email protected]@vestamt.dk

Current Age(mo)

Gen-der

Diagnosis Epilepsy

onset(mo)

Diet

start(mo)

EEG

before KD

1 19 FCryptogenic West

Syndrome 4 10 Hypsarritmia

2 22 MSymptomatic West

Syndrome

(Deletion 22q13)9 16 Hypsarritmia

3 18 MSymptomatic West

Syndrome

(Trisomy 21-Down S.)5 12

Hypsarritmia

4 18 FEarly Myoclonic Encephalopathy 6 12 Suppression-burst

5 18 MCryptogenic West

Syndrome 4 13 Multifocal

6 16 MSymptomatic West Syndrome (Multiple

cerebral malformations)2 12 Multifocal

7 25 MCryptogenic West

Syndrome 3 21 Hypsarritmia

8 18 MCryptogenic West

Syndrome 3 15 Hypsarritmia

Seizures

before

KD(mean/week)

Seizures

after

1 mo(mean/week)

Seizures

after

3 mo(mean/week)

Seizures

after

6 mo(mean/week)

Total Seizure

reduction

EEG

at

follow-up

1 80 18 11 10 88 % Multifocal

2 210 0 0 0 100 % n/a

3 20 19 18 out of diet 10 % Hypsarritmia

4 76 57 12 62 18 % Slight improvement

5 450 113 63 n/a 86 % n/a*

6 120 147 37 n/a 68 % n/a*

7 60 29 20 n/a 66 % n/a*

8 40 28 20 n/a 50 % Multifocal

Diet start

Kcal / Ratio / Carbsxday

Diet after 1 mo

Kcal / Ratio / Carbsx day

Diet after 3 mo

Kcal / Ratio / Carbsxday

Diet after 6 mo

Kcal / Ratio / Carbsxday

1 720 / 4:1 / 5,5 g 720 / 4:1 / 5,5 g 750 / 4:1 / 5,5 g 860 / 4:1 / 5,5 g

2 550 / 4:1 / 2 g 700 / 3,5:1 / 5 g 700 / 3,5:1 / 5 g 810 / 3,5:1 / 5 g

3 550 / 4:1 / 2,3 g 580 / 4:1 / 2,4 g 680 / 4:1 / 2,8 g out of diet

4 450 / 3:1 / 1,8 g 525 / 3:1 / 2,1 g 565 / 3:1 / 2,1 g 610 / 4:1 /2,3 g

5 600 / 3:1 / 4 g 600 / 3:1 / 4 g 600 / 4:1 / 4 g n/a*

6 700 / 4:1 / 4 g 600 / 4:1 / 3 g 450 / 4:1 / 3 g n/a*

7 700 / 4:1 / 5 g 700 / 4:1 / 5 g 700 / 4:1 / 5 g n/a*

8 565 / 3:1 / 3,5 g 605 / 3:1 / 3,5 g 617 / 4:1 / 2,5 g n/a*

*n/a= non available

References: ¹Cochrane Database Syst Rev 2002; ²Kossoff EH, Pediatrics 2002; ³Eun SH et al, Brain Dev 2006

Patient 1